Novartis | NOVN - Equity Capital And Reserves

Stock Price
120.30
Daily Change
1.02 0.86%
Monthly
5.90%
Yearly
24.24%
Q1 Forecast
111.83

Novartis reported $44.75B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Alcon AG USD 22.09B 44M Sep/2025
Almirall EUR 1.46B 25.28M Jun/2025
Amgen USD 9.62B 2.19B Sep/2025
AstraZeneca USD 45.89B 1.17B Sep/2025
Autolus Therapeutics Ltd USD 265.45M 81.01M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 12.95B 1.38B Sep/2025
Galapagos EUR 2.45B 196.86M Sep/2025
Genmab DKK 5.3B 6M Jun/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.18B 2.42B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
J&J USD 78.47B 0 Sep/2025
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.94B 677M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novartis USD 44.33B 2.28B Sep/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Orion EUR 1.02B 99.5M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Philips EUR 10.58B 204M Sep/2025
Recordati EUR 1.93B 57.32M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024